Skip to main content
Caplight Logo









Ascendia Pharmaceutical Solutions

Ascendia Pharmaceutical Solutions

Private
New JerseyHealthcare & Life Scienceshttps://ascendiacdmo.com/

Last Round

Seed Round

Jul 24, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ascendia Pharmaceutical Solutions is a pharmaceutical company that provides contract development and manufacturing (CDMO) services, including pre-formulation, formulation development, and cGMP manufacturing for a variety of dosage forms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOformulation developmentcontract development and manufacturing organizationdrug solubilityspecialty CDMOcGMP manufacturingbioavailability enhancementlipid nanoparticle technologyLNPspharma outsourcingdrug deliverysterile manufacturingclinical trial material supplyCTM supplypharmaceutical nanotechnologyamorphous solid dispersionanalytical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ascendia Pharmaceutical Solutions Comparables

Compare Ascendia Pharmaceutical Solutions with similar companies based on industry and business-model similarity.

Ascendia Pharmaceutical Solutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phosphorex
87%
Serán Bioscience
86%
Latitude Pharmaceuticals Inc.
86%

Ascendia Pharmaceutical Solutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 24, 2026
Growth EquityApr 8, 2021

Ascendia Pharmaceutical Solutions Investors

Notable investors and investment history

Ascendia Pharmaceutical Solutions investors
InvestorRounds
Signet Healthcare PartnersGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Raised $4.1M in Seed funding.

  • Apr 8, 2021

    Raised Growth Equity round led by Signet Healthcare Partners.

Ascendia Pharmaceutical Solutions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ascendia Pharmaceutical Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ascendia Pharmaceutical Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey
Year Founded2012
Last FundingJul 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?